Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer
2006

Real-time PCR for HER-2/neu Status in Breast Cancer

Sample size: 39 publication Evidence: high

Author Information

Author(s): Nistor Andreea, Watson Peter H, Pettigrew Norman, Tabiti Karim, Dawson Angelika, Myal Yvonne

Primary Institution: University of Manitoba

Hypothesis

Does real-time PCR provide an accurate alternative for determining HER-2/neu status compared to FISH?

Conclusion

Real-time PCR analysis using the LightCycler is a viable alternative to FISH for evaluating breast tumors with indeterminate IHC scores.

Supporting Evidence

  • The study found a 92% concordance between FISH and real-time PCR results.
  • 10% of tumors were positive for gene amplification by both methods.
  • Real-time PCR is simpler and faster than FISH.

Takeaway

This study shows that a new test called real-time PCR can help doctors check if a breast cancer patient has a specific gene that can affect treatment, and it works well compared to the older test.

Methodology

The study compared the results of real-time PCR and FISH on 39 breast tumors with an IHC score of 2+.

Limitations

The study focused only on tumors with an indeterminate IHC score, which may limit the generalizability of the findings.

Statistical Information

P-Value

0.0009

Confidence Interval

95%

Statistical Significance

p < 0.0009

Digital Object Identifier (DOI)

10.1186/1472-6890-6-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication